You are here:
Home:
Audio Program Guide
:
BCU Nurses 3 | 2007 Audio
:
BCU Nurses 3 | 2007
Go to interview with
Peter M Ravdin, MD, PhD
Go to interview with Lillie Shockney, RN, BS, MAS
Go to interview with Ms G
Go to interview with Ms K
To listen to individual tracks now, click on the track you wish to listen to.
To download tracks, right-click on the one you wish to download.
Peter M Ravdin, MD, PhD
Clinical Professor of Medicine
The University of Texas
Health Science Center at San Antonio
San Antonio, Texas
Click here to download the entire interview
Track 1
Reduction in the use of menopausal hormone replacement therapy as a contributor to
a decline in breast cancer incidence
Track 2
Data from randomized clinical trials evaluating hormone replacement therapy
Track 3
Revision of national guidelines regarding the use of hormone replacement therapy
Track 4
Benefits and risks associated with progesterone in hormone replacement therapy
Track 5
Short-term side effects of cytotoxic chemotherapy
Track 6
Neutropenia and fatigue secondary to chemotherapy
Track 7
Leukemia and cardiotoxicity risks associated with the use of anthracyclines
Track 8
Doxorubicin/cyclophosphamide (AC) versus docetaxel/cyclophosphamide (TC) in the adjuvant setting
Track 9
Side effects of docetaxel
Track 10
Cardiotoxicity of adjuvant docetaxel/carboplatin/trastuzumab versus AC
docetaxel/ trastuzumab combinations
Track 11
Risk of congestive heart failure with trastuzumab versus anthracyclines
Track 12
Role of nonanthracycline-based regimens in the adjuvant setting
Track 13
Adjuvant aromatase inhibitors versus tamoxifen in postmenopausal patients
Track 14
Toxicity profiles of tamoxifen versus aromatase inhibitors
Track 15
Management of arthralgias secondary to aromatase inhibitors
Lillie Shockney, RN, BS, MAS
Administrative Director of Breast Center
Instructor, Faculty — Dept of Surgery
Johns Hopkins University School of Medicine
Johns Hopkins Avon Foundation
Breast Center
Baltimore, Maryland
Click here to download the entire interview
Track 1
Personal history of two breast cancers
Track 2
Management of tamoxifen-related side effects
Track 3
Understanding the mind-set of a patient with newly diagnosed breast cancer
Track 4
Clinical use of the Onco
typ
e DX™ assay
Track 5
Enrolling patients on the TAILORx trial
Track 6
Patient adherence with oral endocrine therapy
Track 7
Likelihood of adherence to long-term endocrine therapy
Track 8
Helping patients understand and manage arthralgias secondary to aromatase inhibitors
Track 9
Impact of adjuvant trastuzumab on quality of life
Track 10
Providing emotional support for patients with newly diagnosed metastatic disease
Track 11
Dealing with cancer as a survivor and healthcare professional
Track 12
Impact of bevacizumab on progression-free survival and quality of life
Track 13
Potential benefits of nanoparticle albumin-bound (
nab
) paclitaxel
Track 14
Administration and tolerability of fulvestrant
Track 15
Psychosocial support for patients with metastatic breast cancer
Ms G
Click here to download the entire interview
Track 1
Patient interview: A 49-year-old physician with ER-negative, PR-negative, HER2-positive,
node-negative breast cancer
Track 2
Management and prevention of neutropenia secondary to chemotherapy
Track 3
Patient’s experience with treatment-related side effects
Track 4
Cognitive impairment associated with chemotherapy
Track 5
Personal perspective on delayed adjuvant trastuzumab
Track 6
Dealing with teenage daughters when diagnosed with breast cancer
Track 7
Change in personal outlook and life perspective after breast cancer
Track 8
Patient’s advice on coping with cancer
Ms K
Click here to download the entire interview
Track 1
Patient interview: A 55-year-old woman treated eight years ago for ER-positive, HER2-negative breast cancer with one positive node
Track 2
Patient’s experience with chemotherapy-related side effects
Track 3
Management of hot flashes secondary to endocrine therapy
Track 4
Impact of cancer on a patient’s relationships and outlook on life
Search Our Site:
Terms and Conditions of Use of General Disclaimer
|
Privacy Policy
Copyright © 2007 Research To Practice, All Rights Reserved